Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. - Test2 - elhamkhani - TriplyDB

Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

http://www.wikidata.org/entity/Q34339177

about

The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model.Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid.Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders.Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.Endocannabinoid Signaling in Autism Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome Epigenetic findings in autism: new perspectives for therapy.Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages Perspectives on the use of stem cells for autism treatment MicroRNA-323-3p with clinical potential in rheumatoid arthritis, Alzheimer's disease and ectopic pregnancy.Downstream effects of endocannabinoid on blood cells: implications for health and disease.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Melanocortin receptor agonists MCR1-5 protect photoreceptors from high-glucose damage and restore antioxidant enzymes in primary retinal cell culture.Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention.The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.Intraperitoneal Administration of Oxygen/Ozone to Rats Reduces the Pancreatic Damage Induced by Streptozotocin.Plasma anandamide concentrations are lower in children with autism spectrum disorder.Stem cell therapy in autism: recent insights The Melanocortin MC5R as a New Target for Treatment of High Glucose-Induced Hypertrophy of the Cardiac H9c2 Cells

P2860

Q28388719-B7A1DE25-A9F9-4FF7-B0B5-25E58F11B05D Q30418368-7C286822-4621-4F63-908C-9172F141BF41 Q30818488-BB2325D3-7687-4B82-BC6F-A5BFBDA529AA Q36140008-7D490A5D-6915-4F1B-8C62-62E699E1C633 Q36150334-2485B4A2-168C-46B9-98A9-0B12232D90D9 Q36157617-1938572E-C200-4688-A740-CBDC9AF384A6 Q36719661-FADD50EB-32A0-4416-831A-BD4E006EC9B0 Q37237028-26457925-84A1-463E-9559-F0DC63466598 Q37300512-CA8CF808-FF4C-4F15-9A5E-96514C88768D Q37718217-97E590D9-71CB-40A2-9AA5-87E0295B7702 Q38162181-630F7A6B-DB68-4478-BA02-135D0FA52207 Q38166774-68224AC7-BA94-4FFC-B267-1F977B28FD51 Q38468985-0F9F1B6B-2BBE-4A4A-80BD-19EBC7CBD9B3 Q38503842-0A336350-5A44-4971-ACC3-C7DD7C3BA714 Q39082408-7A87B913-6452-4624-BAA8-A0107396EBBD Q39411024-D4ED27E9-669C-4834-9D02-3DC2FF82E3E1 Q41176818-439ED510-20FD-4672-A1AC-EE9DA3FC28B4 Q41660878-E1713E48-DC0E-4EFD-A39A-7504B99BB157 Q41706699-7B9B0019-D5A0-4728-A2FF-6813F9AFB674 Q47556874-A71A2B55-4813-480E-B1B1-12529A6A5F4A Q52643582-5CB1EF3A-A2FC-4927-A492-9D06A7FD2C07 Q58698694-5F09D985-E760-4E5F-8D43-DE9DD4D2B79A Q58707465-392E4887-F7E4-4E14-A156-DED467C536B6

P2860

Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

http://www.wikidata.org/entity/Q34339177

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@ast

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@en

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@nl

type

label

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@ast

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@en

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@nl

prefLabel

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@ast

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@en

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@nl

P1433

Q34339177-659457B0-AE6D-4337-A954-15ACABB61903

P1476

Q34339177-7171DAD3-B263-45DE-8405-6B7327505966

P2093

Q34339177-36200FAB-0EDB-4930-8D35-021A9433E91B

Q34339177-4BC95129-0A8E-4495-BA27-961BA2E95D60

Q34339177-55BF5BDD-4B40-44F3-BE31-87E1715B025D

Q34339177-5713E024-6FA6-4644-855B-A361E3B2B13C

Q34339177-87111E2A-D470-40AF-BBEF-D0A48FC99B49

Q34339177-ADDBEE97-62AE-4D00-8A02-04EE2CE9B7DC

Q34339177-C26B9683-31C7-44F3-985E-0555C7114BF2

Q34339177-E1EBA219-959F-4748-A48E-0C14CC376185

Q34339177-E34C2525-82C7-4C2E-BBF0-BFA58AD35468

P2860

Q34339177-05C7406F-015E-4516-B436-6209C1492A0A

Q34339177-0C07F50C-0D46-49E1-9F69-D6B4AD804172

Q34339177-156306B3-BA0C-438D-809E-6F28CD1733BE

Q34339177-1CC5CD0F-3005-48EA-B63E-0CDFAD6F0683

Q34339177-1CE9C9A3-F0DF-4AB8-ADAB-4FBF4000F1DD

Q34339177-2B162918-9CCA-4F54-8F76-9BF41ADC4266

Q34339177-352AA2FA-2E1F-4354-A8A6-2985D0633424

Q34339177-3658D5C8-56F8-4FE4-9686-7ADF1CD299A7

Q34339177-433F707A-FE6E-46E1-B9C7-C7CA3ABC2478

Q34339177-441516DD-DAFC-4ECE-916F-6D57AED20AD0

P2888

Q34339177-397FECE7-F17E-4506-A710-CF25DCFE83CE

P304

Q34339177-99123D7A-7935-41D0-B9CA-54042761B169

P31

Q34339177-DA611039-3054-4BE9-B6A1-8B7278FB1070

P356

Q34339177-CCBE2442-62E8-4EC2-B09E-5F046A1DA285

P407

Q34339177-8FC78D44-A50E-4D6D-892E-1C014DB6F96F

P433

Q34339177-656931BD-6224-403F-B14D-2AF0124095DB

P478

Q34339177-B6E95ACC-5102-46E7-AAFE-F95519FE6518

P50

Q34339177-F152A089-F2DE-4808-882D-0B54EF647942

P577

Q34339177-473B43D4-6DED-4867-A49C-3CFFCF2025FD

P5875

Q34339177-94689B7F-66DC-433E-A6D7-1ECC96D38FC8

P6179

Q34339177-E8583E5D-4677-4CA5-8AE1-8F7ECF974AA7

P698

Q34339177-10A4D08B-FA16-4A22-B5BB-07C1D04B8809

P921

Q34339177-270C9203-DF8E-4566-9E83-49C228470C6A

Q34339177-292DA270-9423-428C-AB79-558EAF59A733

Q34339177-47D8A22B-311E-4CE9-B3D1-9730CC4D4BC9

Q34339177-f090b6bf-f777-4ea6-8b80-1e6797232ed7

P356

S10803-013-1824-9

P1433

Journal of Autism and Developmental Disorders

P1476

Cannabinoid receptor type 2, b ...... ffected by autistic disorders.

@en

P2093

Alessandra Cirillo

http://www.w3.org/2001/XMLSchema#string

Anna Sapone

http://www.w3.org/2001/XMLSchema#string

Catia Giordano

http://www.w3.org/2001/XMLSchema#string

Dario Siniscalco

http://www.w3.org/2001/XMLSchema#string

Francesco Rossi

http://www.w3.org/2001/XMLSchema#string

James Jeffrey Bradstreet

http://www.w3.org/2001/XMLSchema#string

Laura de Magistris

http://www.w3.org/2001/XMLSchema#string

Nicola Antonucci

http://www.w3.org/2001/XMLSchema#string

Sabatino Maione

http://www.w3.org/2001/XMLSchema#string

P2860

The immune response in autism: a new frontier for autism research

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Regulation of G protein-coupled receptor function by Na+/H+ exchange regulatory factors

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

Correlation between protein and mRNA abundance in yeast

Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system

Messenger RNA turnover in eukaryotes: pathways and enzymes

P2888

s10803-013-1824-9

P304

2686-2695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10803-013-1824-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236181731

http://www.w3.org/2001/XMLSchema#string

P6179

1012528023

http://www.w3.org/2001/XMLSchema#string

P698

23585028

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor